At Biostrategix, we supply the CJC-1295 ipamorelin 250mcg strip, matched at 250mcg of each compound per film. Offered as a needle-free CJC ipamorelin research format, the CJC ipamorelin strip 30 count pack draws from a single lot. CJC-1295 is a growth hormone releasing hormone analog. Ipamorelin is a pentapeptide acting at the ghrelin receptor, an entirely separate system.
Why CJC-1295 and Ipamorelin Are Combined in Research
The two are combined because they stimulate growth hormone release through separate receptor systems, and co-administration in humans produces a larger response than either produces alone. Native GHRH is not a practical research tool on its own, being inactivated within minutes by a plasma dipeptidylaminopeptidase that cleaves the amino terminus.Â
The Two Forms of CJC-1295
The compound named CJC-1295 exists in two forms,. The original characterisation work described a modified hGRF(1-29) analog designed to bioconjugate to serum albumin, reporting a 4-fold increase in GH area under the curve against the unmodified peptide in rats.
That albumin-binding version is the one designated with DAC, and it carries the long-duration human data. Two randomised, placebo-controlled trials in healthy adults aged 21 to 61 reported a half-life of 5.8 to 8.1 days, with a separate human study finding it binds permanently to endogenous albumin while preserving normal pulsatile secretion.
GHRH + GHRP: Two Independent Receptor Systems, One Synergistic Stack
The mechanistic basis for this pairing is that the two compounds act on different receptors coupled to different second messenger systems, which is why their effects combine rather than overlap.
The Two Receptor Systems
GHRH acts on a G-protein-coupled receptor on pituitary somatotrophs that activates adenylyl cyclase and cAMP. Ghrelin acts through a separate receptor that activates phospholipase C, raising IP3, DAG and cytosolic calcium.
Ipamorelin occupies the second of those systems. The original characterisation paper described it as a pentapeptide with high potency and efficacy in vitro and in vivo, studied in primary rat pituitary cells, anaesthetised rats and conscious swine.
Its selectivity is why it displaced earlier peptides in research use: GHRP-6 and GHRP-2 both raised plasma ACTH and cortisol, while ipamorelin did not raise ACTH or cortisol at levels significantly different from GHRH stimulation.
The Synergistic Response
The synergy is documented in humans. In 18 normal men, submaximal doses of a growth hormone releasing peptide combined with GHRH stimulated GH release synergistically, producing more than either peptide alone.
Later human work co-administering low-dose ghrelin with GHRH found the same pattern, and reviews of the class report combined administration producing a 54-fold increase in pulsatile GH secretion against controls.
That evidence concerns acute hormone release measured as a surrogate marker, which is the endpoint this compound class is characterised on.
Ipamorelin in Human Trials
Ipamorelin has been through a randomised controlled human trial, in 114 adults undergoing bowel resection, where it was well tolerated across the study population. The trial measured recovery of gastrointestinal function rather than any endpoint relating to body composition, and reported a median 25.3 versus 32.6 hours to first tolerated meal.
Sublingual Strip vs Injectable Format for GH Research
The difference between these formats is preparation and documentation. A film arrives with its content set at manufacture, while a lyophilized vial requires diluent, measurement and management of a reconstituted solution.
Orodispersible films are an established dosage form, built from polymers such as pullulan and hypromellose. They weigh under 200 mg in total, which reserves the formulation space for potent active ingredients, and a combined 500mcg payload sits well inside that envelope.
The practical advantages are procedural: content per unit is fixed before shipping, the material is handled dry, and no reconstituted solution has to be stored or stability-tracked across a working period. No injection CJC ipamorelin research removes several preparation steps before any measurement begins.
GH Secretagogue Dissolvable Strip Applications
- A fixed-content film suits several in vitro workflows directly. Dissolution profiling under standardised conditions, content uniformity across a lot, and stability under controlled temperature and humidity are all measurable on the unit as supplied.
- Comparative formulation work is the second application. With mass per unit set at manufacture, a film can be assessed against a reconstituted solution of known concentration without preparation variance entering the comparison.
- Analytical method development is the third. A solid dosage form with a defined polymer matrix gives a consistent sample for extraction, recovery and assay validation work.
250mcg / 250mcg Per Strip — Research Dose Context
Each film is labelled at 250mcg of CJC-1295 and 250mcg of ipamorelin, a matched 1:1 ratio totaling 500mcg per strip. This 250mcg/250mcg formulation is increasingly becoming the modern market standard, moving past older 150mcg formulas to deliver higher research utility per unit.
Content per unit is where films differ most from vials. A lyophilized vial’s working concentration depends on how much diluent is added and how precisely it is measured, so two researchers working from identical vials can arrive at different concentrations.
A matched ratio also holds the intended proportion constant, ensuring observed differences between conditions stem from experimental variables rather than a shifting balance between compounds.Â
Can GH Peptides Be Absorbed Through the Mouth?
The CJC-1295 ipamorelin sublingual strip sits within a defined set of transport parameters, and the two compounds occupy different points in that space.
The Transport Parameters
The buccal barrier presents an effective pore radius of 1.5 to 3 nm. Compounds above 500 Da permeate at low rates, and most peptides exceed 1000 Da.
Mucosal enzyme activity, residence time under salivary flow and the swallowed fraction are the three further variables governing any peptide held in the oral cavity.
Reported bioavailability for peptides delivered buccally or sublingually sits in the range of 1% to 2%, and the FDA-approved sublingual desmopressin product documents 0.25 percent from an optimised commercial tablet.
Where These Two Compounds Sit
Ipamorelin is a pentapeptide and sits closest to the permeability threshold of anything in this catalogue. The CJC-1295 component is a 29-residue peptide several times larger. The two components of this film are therefore distinct candidates by this route, which is itself a reason to study them in a format that holds both at a known content.
Permeation Enhancers
Sodium caprate temporarily opens intercellular tight junctions and increases membrane fluidity, performing comparably to the established benchmark in the gastrointestinal work reporting it.
Cyclodextrins act primarily as solubilisers, carrying a compound to the membrane surface where the complex dissociates.
Transmucosal delivery of these two peptides has not yet been quantified, and a fixed-content film is the format that makes that work tractable.
Certificate of Analysis & Purity Documentation
Biostrategix publishes third-party certificates of analysis in the Certificates of Analysis library, with testing by MDx Biolabs, MZ Biolabs and Zyntro Analytical Lab Solutions, and separate endotoxin testing on many entries. A research grade CJC ipamorelin strip is defined by that documentation as much as by its content.
At $85 for 30 strips, Biostrategix provides exceptional value—offering a 43% savings compared to other brands ($145) and clinic operators ($149) for the exact same 250mcg/250mcg dose, while maintaining rigorous research-grade COA documentation.
Storage & Handling
Store sealed strips in a cool, dry place away from direct light, and keep the pouch closed until a strip is required. The property that makes a film disintegrate on contact with moisture also makes it responsive to ambient humidity.
Humidity control preserves both film integrity and the stability of what the film carries. Record lot number, receipt date and storage conditions alongside experimental data, since long-term film stability is not yet characterised for either compound.
Related Formats in the Catalogue
Both compounds are supplied individually in vial format, as CJC-1295 no DAC lyophilized powder and as ipamorelin lyophilized powder. Sourcing the individual vials alongside the film allows the contribution of each component to be separated, and allows the film to be compared against a solution of known concentration.
For related growth hormone axis work the catalogue also carries sermorelin and tesamorelin, both GHRH analogs with distinct modifications. At Biostrategix, we offer five confirmed sublingual dissolvable strip products engineered for specific research applications:
- BPC-157 (500mcg): Targeted tissue repair and gut barrier integrity research format.
- BPC-157 + TB-500 (500mcg/500mcg): Dual-action tissue regeneration and cellular migration recovery blend.
- CJC-1295 + Ipamorelin (250mcg/250mcg): Synergistic growth hormone axis secretagogue stack in a matched ratio.
- GLP-R / Retatrutide (2mg): Triple agonist (GLP-1/GIP/Glucagon) formulation for metabolic research.
- PT-141 / Bremelanotide (2mg): Single-compound melanocortin receptor agonist format for central nervous system and sexual health research.
Buy CJC Ipamorelin Oral Strip Research Material
Biostrategix stocks the CJC-1295 ipamorelin dissolvable strip in a 30-count pack, shipped from California, with orders typically dispatched within 48 hours.Â
Certificates of analysis for the catalogue are published openly, and lot documentation is available on request against the lot number printed on the pouch.
Order the CJC-1295 ipamorelin 250mcg dissolvable strip from Biostrategix.
Frequently Asked Questions
Why combine CJC-1295 and Ipamorelin?
Because they act on separate receptor systems coupled to different second messenger pathways. Human studies of a GHRH analog combined with a growth hormone releasing peptide reported synergistic GH release, greater than either produced alone.
What is the difference between CJC-1295 with and without DAC?
The DAC modification lets the peptide bioconjugate to serum albumin, extending its half-life to a reported 5.8 to 8.1 days in human trials. The no-DAC form behaves like its unmodified parent, whose published half-life is measured in minutes. The two are distinct in study design, and the certificates for this material identify it as the no-DAC form.
Why is ipamorelin preferred over older growth hormone releasing peptides?
Selectivity. In the original characterisation work GHRP-6 and GHRP-2 raised plasma ACTH and cortisol, while ipamorelin did not raise either above the levels seen with GHRH alone, and did not affect FSH, LH, prolactin or TSH.
What in vitro work does this format support?
Dissolution profiling, content uniformity across a lot and stability testing under controlled temperature and humidity are all measurable on the unit as supplied. For a two-compound film there is a further application: assessing the ratio of the two actives across units, which is what a matched-content formulation is designed to hold constant.
Can CJC-1295 and Ipamorelin actually absorb through the mouth?
Yes, transmucosal peptide absorption is supported by mucosal permeability studies, particularly because the sublingual and buccal mucosa is highly vascularized and allows compounds to directly enter systemic circulation. At 1,025 Da for ipamorelin and 3,368 Da for CJC-1295 (no DAC), these peptides are significantly smaller than 39-amino-acid GLP-1 class compounds, placing them closer to the mucosal permeability threshold.
Formulations utilizing permeation enhancers and solubilizers, such as Sodium Caprate to temporarily open tight junctions and Beta Cyclodextrin to shuttle molecules to the membrane surface, further enhance transmucosal transport and absorption efficiency.
How should a lot be verified on receipt?
Match the lot number printed on the pouch against the certificate for that lot, and confirm the certificate covers the strip format and both actives. For this product specifically, confirm the certificate identifies the CJC-1295 component as the no-DAC form at 3,367.90 g/mol before designing around any published pharmacokinetic figure.
What does the 30-strip format offer?
A 30-strip pack provides a single lot across an extended working period, keeping lot-to-lot variation out of a sequence of related experiments. Each unit is individually sealed, so opening one strip leaves the remainder of the pack unaffected.
Legal Disclaimer
These products are intended as research materials only.
This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website is for educational purposes only. Bodily introduction of any kind into humans or animals is strictly forbidden by law and is not endorsed by this website. This product should only be handled by licensed, qualified professionals. This product is not a drug, food, or cosmetic and may not be misbranded, misused, or mislabeled as a drug, food, or cosmetic.





Reviews
There are no reviews yet.